In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...

According to the suit, the PBMs collected billions of dollars in rebates and fees while insulin became increasingly ...

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

The retrospective study involved reviewing the medical charts of 100 adults with T1D ... All of the participants were taking insulin for their diabetes. Insulin pumps were used by 75% of those ...

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the ...

WEDNESDAY, Sept. 11, 2024 (HealthDay News) -- Weekly insulin shots can help control both type 1 and type 2 diabetes as well ...

Senator Sanders (I-Vt.) says CEOs of generic drugmakers are willing to sell Novo Nordisk’s (NVO) blockbuster obesity medicine ...

Application error: a client-side exception has occurred (see the browser console for more information).